| UniProt ID | ZN282_HUMAN | |
|---|---|---|
| UniProt AC | Q9UDV7 | |
| Protein Name | Zinc finger protein 282 | |
| Gene Name | ZNF282 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 671 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Binds to the U5 repressive element (U5RE) of the human T cell leukemia virus type I long terminal repeat. It recognizes the 5'-TCCACCCC-3' sequence as a core motif and exerts a strong repressive effect on HTLV-I LTR-mediated expression.. | |
| Protein Sequence | MQFVSTRPQPQQLGIQGLGLDSGSWSWAQALPPEEVCHQEPALRGEMAEGMPPMQAQEWDMDARRPMPFQFPPFPDRAPVFPDRMMREPQLPTAEISLWTVVAAIQAVERKVDAQASQLLNLEGRTGTAEKKLADCEKTAVEFGNHMESKWAVLGTLLQEYGLLQRRLENLENLLRNRNFWVLRLPPGSKGEAPKVPVTFVDIAVYFSEDEWKNLDEWQKELYNNLVKENYKTLMSLDAEGSVPKPDAPVQAEPREEPCVWEQRHPEEREIPMDPEAGAEPLVPAQDASSQVKREDTLCVRGQRGLEERAIPTESITDSPISAQDLLSRIKQEEHQCVWDQQDLADRDIPTDPNSESLISAHDILSWIKQEEQPYPWGPRDSMDGELGLDSGPSDSLLMVKNPPPAPPQPQPQPQPPQPQLQSQPQPQSLPPIAVAENPGGPPSRGLLDDGFQVLPGERGSGEAPPGGDRSTGGGGGDGGGGGGGAEAGTGAGGGCGSCCPGGLRRSLLLHGARSKPYSCPECGKSFGVRKSLIIHHRSHTKERPYECAECEKSFNCHSGLIRHQMTHRGERPYKCSECEKTYSRKEHLQNHQRLHTGERPFQCALCGKSFIRKQNLLKHQRIHTGERPYTCGECGKSFRYKESLKDHLRVHSGGPGPGAPRQLPPPPERD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 111 | Ubiquitination | AIQAVERKVDAQASQ HHHHHHHHHHHHHHH | 30.84 | - | |
| 111 | Ubiquitination | AIQAVERKVDAQASQ HHHHHHHHHHHHHHH | 30.84 | - | |
| 156 | Phosphorylation | SKWAVLGTLLQEYGL HHHHHHHHHHHHHHH | 21.82 | - | |
| 161 | Phosphorylation | LGTLLQEYGLLQRRL HHHHHHHHHHHHHHH | 10.50 | 17053785 | |
| 190 | Ubiquitination | LRLPPGSKGEAPKVP EECCCCCCCCCCCCC | 67.68 | - | |
| 228 | Ubiquitination | ELYNNLVKENYKTLM HHHHHHHHHHHHHHH | 43.33 | 21890473 | |
| 228 | Ubiquitination | ELYNNLVKENYKTLM HHHHHHHHHHHHHHH | 43.33 | 21890473 | |
| 232 | Ubiquitination | NLVKENYKTLMSLDA HHHHHHHHHHHCCCC | 46.92 | 21890473 | |
| 232 | Ubiquitination | NLVKENYKTLMSLDA HHHHHHHHHHHCCCC | 46.92 | - | |
| 245 | Ubiquitination | DAEGSVPKPDAPVQA CCCCCCCCCCCCCCC | 54.06 | - | |
| 293 | Sumoylation | QDASSQVKREDTLCV CCCCHHCCCCCCEEE | 42.29 | - | |
| 293 | Ubiquitination | QDASSQVKREDTLCV CCCCHHCCCCCCEEE | 42.29 | - | |
| 293 | Sumoylation | QDASSQVKREDTLCV CCCCHHCCCCCCEEE | 42.29 | 28112733 | |
| 313 | Phosphorylation | LEERAIPTESITDSP CCCCCCCCCCCCCCC | 35.93 | 26074081 | |
| 315 | Phosphorylation | ERAIPTESITDSPIS CCCCCCCCCCCCCCC | 33.01 | 26074081 | |
| 317 | Phosphorylation | AIPTESITDSPISAQ CCCCCCCCCCCCCHH | 39.44 | 26074081 | |
| 319 | Phosphorylation | PTESITDSPISAQDL CCCCCCCCCCCHHHH | 18.58 | 25159151 | |
| 322 | Phosphorylation | SITDSPISAQDLLSR CCCCCCCCHHHHHHH | 24.22 | 26074081 | |
| 328 | Phosphorylation | ISAQDLLSRIKQEEH CCHHHHHHHHHHHHH | 38.98 | 26074081 | |
| 331 | Sumoylation | QDLLSRIKQEEHQCV HHHHHHHHHHHHCCC | 51.01 | - | |
| 331 | Sumoylation | QDLLSRIKQEEHQCV HHHHHHHHHHHHCCC | 51.01 | - | |
| 331 | Ubiquitination | QDLLSRIKQEEHQCV HHHHHHHHHHHHCCC | 51.01 | - | |
| 369 | Sumoylation | HDILSWIKQEEQPYP HHHHHHHHHCCCCCC | 45.45 | - | |
| 369 | Ubiquitination | HDILSWIKQEEQPYP HHHHHHHHHCCCCCC | 45.45 | - | |
| 369 | Sumoylation | HDILSWIKQEEQPYP HHHHHHHHHCCCCCC | 45.45 | - | |
| 382 | Phosphorylation | YPWGPRDSMDGELGL CCCCCCCCCCCCCCC | 21.76 | - | |
| 391 | Phosphorylation | DGELGLDSGPSDSLL CCCCCCCCCCCCCEE | 58.61 | - | |
| 394 | Phosphorylation | LGLDSGPSDSLLMVK CCCCCCCCCCEEEEC | 43.27 | - | |
| 507 | Phosphorylation | CPGGLRRSLLLHGAR CCCHHHHHHHHCCCC | 19.55 | 27251275 | |
| 515 | Phosphorylation | LLLHGARSKPYSCPE HHHCCCCCCCCCCCC | 37.13 | - | |
| 516 | Acetylation | LLHGARSKPYSCPEC HHCCCCCCCCCCCCC | 42.28 | 26051181 | |
| 518 | Phosphorylation | HGARSKPYSCPECGK CCCCCCCCCCCCCCC | 27.00 | 30576142 | |
| 519 | Phosphorylation | GARSKPYSCPECGKS CCCCCCCCCCCCCCC | 31.55 | 30576142 | |
| 532 | Phosphorylation | KSFGVRKSLIIHHRS CCCCCCCEEEEECCC | 17.78 | 27251275 | |
| 597 | Phosphorylation | QNHQRLHTGERPFQC HHHCCCCCCCCCHHH | 45.38 | 25159151 | |
| 625 | Phosphorylation | LKHQRIHTGERPYTC HHCCCCCCCCCCEEC | 38.06 | - | |
| 653 | Phosphorylation | KDHLRVHSGGPGPGA HHHEEECCCCCCCCC | 42.46 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN282_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN282_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN282_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of ZN282_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-161, AND MASSSPECTROMETRY. | |